The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Rambam Health Care Campus.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01509898
First received: January 1, 2012
Last updated: January 12, 2012
Last verified: January 2012
  Purpose

The aim of this study was to evaluate the effect of a dental water jet on initial peri-implant disease resolution.


Condition Intervention Phase
Peri-implantitis
Device: Water jet
Phase 1
Phase 2

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease

Resource links provided by NLM:


Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Probing depth [ Time Frame: one month ] [ Designated as safety issue: No ]
    Probing depth around the implant


Secondary Outcome Measures:
  • Bleeding on probing [ Time Frame: one month ] [ Designated as safety issue: No ]
    Bleeding on probing (BOP) around the implant


Estimated Enrollment: 40
Study Start Date: November 2011
Estimated Study Completion Date: July 2012
Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: water-Jet
use of water jet for 1 month
Device: Water jet
use of water jet for a month
Other Name: silonit water jet

Detailed Description:

Peri-implant disease is becoming more frequent during the last decade. Till today, there is no effective evidence-based treatment. The use of water-jet might improve those situations and reduce morbidity and implant loss.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Signed and dated Informed Consent Form.
  • Patient suffer from peri- implant disease
  • Age Eligible for study: 18 year old and older
  • Genders Eligible for study: Both

Exclusion Criteria:

  • Patient substantially fails to comply with the study schedule, or treatment program as described in this Protocol.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01509898

Contacts
Contact: Dr. liran Levin, DMD +972502062820 l_levin@rambam.health.gov.il

Locations
Israel
Rambam Hospital Recruiting
Haifa, Israel
Contact: Dr. Liran levin, DMD    972    l_levin@rambam.health.gov.il   
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Study Director: Dr. Liran Levin, DMD Department of periodontology
  More Information

No publications provided

Responsible Party: Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT01509898     History of Changes
Other Study ID Numbers: 0374-11-RMB
Study First Received: January 1, 2012
Last Updated: January 12, 2012
Health Authority: Israel: Ethics Commission

Additional relevant MeSH terms:
Peri-Implantitis
Mouth Diseases
Stomatognathic Diseases
Periodontal Diseases

ClinicalTrials.gov processed this record on July 20, 2014